查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1610302

精准心臟病学市场：按产品、样品、技术、适应症、最终用户划分 - 2025-2030 年全球预测

Precision Cardiology Market by Offering (Product, Service), Sample (Blood, Saliva), Technology, Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年精准心臟病学市场价值为138.4亿美元，预计到2024年将达到156.7亿美元，复合年增长率为12.04%，预计到2030年将达到306.8亿美元。

精准心臟病学专注于透过分析患者的遗传、表型和生活方式因素并提供有针对性的治疗来对心血管疾病 (CVD) 进行客製化管理。对精准心臟病学的需求源于心血管疾病（全球主要死亡原因）日益增加的全球负担，需要更个人化和有效的治疗策略。应用范围涵盖风险评估、诊断、治疗监测和药物个人化，为临床环境、研究机构、医疗机构和生物製药公司提供了巨大的最终使用潜力。市场成长的主要驱动力是基因组学和生物技术的进步、个人化医疗的日益采用以及临床医生和患者对精准医疗益处的认识不断提高。关键的成长要素包括政府在基因组学方面的倡议、对医疗保健基础设施的投资以及临床试验的合作研究。目前的机会包括监管适应性、与数位健康平台的整合以及向新兴市场的扩张。然而，基因检测成本的上升、复杂的监管环境、资料隐私问题以及对专业技能的需求正在限制市场的成长。用于资料分析的人工智慧创新、开发具有成本效益的基因组解决方案以及整合多组体学资料以提高准确性，都是业务扩展的有希望的途径。此外，旨在提高相关人员意识和培养信任的综合教育措施可以显着加速市场采用。弥合生物技术开发和临床应用之间差距的多学科合作也将推动业务成长。精准心臟病学市场本质上是动态的，并由快速的技术进步和不断发展的患者照护模式所定义。为了取得成功，公司必须投资于技术开发并建立专注于综合护理模式的策略伙伴关係关係。透过这样做，市场参与者不仅可以利用精准心臟病学的变革潜力，还可以推动创新，改善患者的治疗效果并促进医疗保健的永续性。

主要市场统计
基准年[2023] 138.4亿美元
预计年份 [2024] 156.7亿美元
预测年份 [2030] 306.8亿美元
复合年增长率（%） 12.04%

市场动态：揭示快速发展的精准心臟病学市场的关键市场洞察

供需的动态交互作用正在改变精准心臟病学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心血管疾病盛行率增加
    • 世界各地越来越重视早期疾病筛检
  • 市场限制因素
    • 精准心臟病学相关的高成本
  • 市场机会
    • 精密心臟病学测试的技术进步
    • 政府及企业加大研发投入
  • 市场挑战
    • 监管机构严格的标准和规定

波特五力：驾驭精准心臟病学市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解精准心臟病学市场的外部影响

外部宏观环境因素在塑造精准心臟病学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解精准心臟病学市场的竞争格局

对精密心臟病学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵精密心臟病学市场供应商的绩效评估

FPNV定位矩阵是评估精准心臟科市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製精准心臟病学市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，精准心臟病学市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病盛行率增加
      • 早期疾病筛检的重要性在全球范围内日益增加。
    • 抑制因素
      • 精准心臟病学相关的高成本
    • 机会
      • 精密心臟病学测试的技术进步
      • 政府及企业加大研发投入
    • 任务
      • 监管机构制定的严格标准和规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 精准心臟病学市场：透过提供

  • 产品
  • 服务

第 7 章 精准心臟病学市场样本

  • 血
  • 唾液

第八章精准心臟病学市场：依技术分类

  • 微阵列
  • 次世代定序
  • 聚合酵素链锁反应

第九章精准心臟病学市场（按适应症）

  • 主动脉病变和血管疾病
  • 心律不整
  • 心肌病
  • 先天性心臟疾病和综合征
  • 遗传性高胆固醇症

第 10 章 精准心臟病学市场：依最终使用者分类

  • 学术研究所
  • 医院和诊断实验室

第十一章美洲精准心臟病学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太精准心臟病学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的精准心臟病学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ARUP Laboratories
  • Centogene BV
  • DNA Genotek Inc. by OraSure Technologies, Inc.
  • Eurofins Scientific
  • Exact Sciences Corporation
  • Fulgent Genetics, Inc.
  • GE HealthCare Technologies Inc.
  • Genincode PLC
  • IDOVEN 1903, SL
  • Illumina, Inc.
  • Invitae Corporation
  • OPKO Health, Inc.
  • PerkinElmer Genomics
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5C6F41F5B032

The Precision Cardiology Market was valued at USD 13.84 billion in 2023, expected to reach USD 15.67 billion in 2024, and is projected to grow at a CAGR of 12.04%, to USD 30.68 billion by 2030.

Precision cardiology focuses on the tailored management of cardiovascular diseases (CVDs) by profiling patients' genetic, phenotypic, and lifestyle factors for targeted treatments. The necessity of precision cardiology arises from the rising global burden of CVDs, the leading cause of mortality worldwide, necessitating more personalized and effective treatment strategies. Applications span risk assessment, diagnostics, therapeutic monitoring, and medication personalization, providing significant end-use potential in clinical settings, research institutions, healthcare organizations, and biopharmaceutical companies. Market growth is predominantly driven by advancements in genomics and biotechnology, increasing adoption of personalized medicine, and heightened awareness of precision health benefits among clinicians and patients. Key growth enablers include government initiatives in genomics, investments in healthcare infrastructure, and collaborations for clinical trials. Current opportunities exist in regulatory adaptability, integration with digital health platforms, and expansion into emerging economies. However, market growth is constrained by high costs of genetic testing, complex regulatory landscapes, data privacy concerns, and the need for specialized skills. Innovation in artificial intelligence for data analysis, development of cost-effective genomic solutions, and integration of multi-omics data to enhance precision are promising avenues for business expansion. Moreover, comprehensive educational initiatives to increase stakeholder awareness and foster trust can substantially catalyze market adoption. Business growth can also be supported by interdisciplinary collaborations to bridge gaps between biotechnology developments and clinical applications. The precision cardiology market is inherently dynamic, defined by rapid technological advancements and evolving patient care paradigms. To succeed, companies should invest in technology development and form strategic partnerships focused on integrated care models, while also navigating the regulatory and ethical challenges inherent to the sector. By doing so, market players can not only capitalize on precision cardiology's transformative potential but also drive innovation that enhances patient outcomes and facilitates healthcare sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 13.84 billion
Estimated Year [2024] USD 15.67 billion
Forecast Year [2030] USD 30.68 billion
CAGR (%) 12.04%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Precision Cardiology Market

The Precision Cardiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular diseases
    • Growing emphasis on early disease screening globally
  • Market Restraints
    • High cost associated with precision cardiology
  • Market Opportunities
    • Technological advancements in precision cardiology tests
    • Rise in investment in research and development by governments and businesses
  • Market Challenges
    • Stringent standards and regulations laid by regulatory bodies

Porter's Five Forces: A Strategic Tool for Navigating the Precision Cardiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Precision Cardiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Precision Cardiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Precision Cardiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Precision Cardiology Market

A detailed market share analysis in the Precision Cardiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Precision Cardiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Precision Cardiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Precision Cardiology Market

A strategic analysis of the Precision Cardiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Precision Cardiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ARUP Laboratories, Centogene B.V., DNA Genotek Inc. by OraSure Technologies, Inc., Eurofins Scientific, Exact Sciences Corporation, Fulgent Genetics, Inc., GE HealthCare Technologies Inc., Genincode PLC, IDOVEN 1903, S.L., Illumina, Inc., Invitae Corporation, OPKO Health, Inc., PerkinElmer Genomics, Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Precision Cardiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Product and Service.
  • Based on Sample, market is studied across Blood and Saliva.
  • Based on Technology, market is studied across Microarray, Next-Generation Sequencing, and Polymerase Chain Reaction.
  • Based on Indication, market is studied across Aortopathy and Vascular Diseases, Arrhythmia, Cardiomyopathy, Congenital Heart Defects & Syndromes, and Familial Hypercholesterolemia.
  • Based on End-User, market is studied across Academic & Research Institutes and Hospitals & Diagnostic Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases
      • 5.1.1.2. Growing emphasis on early disease screening globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with precision cardiology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in precision cardiology tests
      • 5.1.3.2. Rise in investment in research and development by governments and businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent standards and regulations laid by regulatory bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Precision Cardiology Market, by Offering

  • 6.1. Introduction
  • 6.2. Product
  • 6.3. Service

7. Precision Cardiology Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Saliva

8. Precision Cardiology Market, by Technology

  • 8.1. Introduction
  • 8.2. Microarray
  • 8.3. Next-Generation Sequencing
  • 8.4. Polymerase Chain Reaction

9. Precision Cardiology Market, by Indication

  • 9.1. Introduction
  • 9.2. Aortopathy and Vascular Diseases
  • 9.3. Arrhythmia
  • 9.4. Cardiomyopathy
  • 9.5. Congenital Heart Defects & Syndromes
  • 9.6. Familial Hypercholesterolemia

10. Precision Cardiology Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Hospitals & Diagnostic Laboratories

11. Americas Precision Cardiology Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Precision Cardiology Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Precision Cardiology Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ARUP Laboratories
  • 3. Centogene B.V.
  • 4. DNA Genotek Inc. by OraSure Technologies, Inc.
  • 5. Eurofins Scientific
  • 6. Exact Sciences Corporation
  • 7. Fulgent Genetics, Inc.
  • 8. GE HealthCare Technologies Inc.
  • 9. Genincode PLC
  • 10. IDOVEN 1903, S.L.
  • 11. Illumina, Inc.
  • 12. Invitae Corporation
  • 13. OPKO Health, Inc.
  • 14. PerkinElmer Genomics
  • 15. Quest Diagnostics Incorporated
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. PRECISION CARDIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. PRECISION CARDIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. PRECISION CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. PRECISION CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECISION CARDIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECISION CARDIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY AORTOPATHY AND VASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY CARDIOMYOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY CONGENITAL HEART DEFECTS & SYNDROMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. PRECISION CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. PRECISION CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023